Tech Company Financing Transactions
MediWound Funding Round
MediWound closed a $30 million investment round on 6/21/2007. Investors included Teva Pharmaceutical Industries and private investors.
Transaction Overview
Company Name
Announced On
6/21/2007
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company's product is currently undergoing Phase III clinical trials in Europe and Phase II trials in the US.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
42 Hayarkon St.
Yavne, 81227
Israel
Yavne, 81227
Israel
Phone
Website
Email Address
Overview
MediWound Ltd. (NASDAQ: MDWD) is a biotechnology niche specialty company. Established in 2001, MediWound is committed to develop, manufacture & commercialize global added value innovative products to address unmet needs in the fields of burn and wound management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sharon Malka
Chief Medical Officer
Lior Rosenberg
Controller
Roni Solomon
Vice President
Andrey Kon
VP - General Counsel
Yaron Meyer
VP - R & D
Eilon Asculai
VP - R & D
Ety Klinger
VP - Regulatory Affairs
Smadar Nestor
Browse more venture capital transactions:
Prev: 6/21/2007: DayLife venture capital transaction
Next: 6/22/2007: Nanostream venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs